Metraipolis › archive › dc_9bf70effd913
The integrated analysis of PRDX3 in lung cancer: biomarker potential and therapeutic target prospects — Europe PMC PMID:42092925
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/42092925
- DOI
- 10.1186/s12931-[numero omesso]-5
- License (as archived)
- solo-consultazione
- Archived
- 2026-10-08T07:03:18.219Z
- SHA-256 of the archived text
975e26c1c8eef435209395a0a843a9f68573684c4d93aad5de5acf674f9f7f8f- Stable URL of this page
https://metraipolis.com/documento/dc_9bf70effd913
How to cite
The integrated analysis of PRDX3 in lung cancer: biomarker potential and therapeutic target prospects — Europe PMC PMID:42092925 — Europe PMC (en), https://europepmc.org/article/MED/42092925 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_9bf70effd913 (Metraipolis archive dc_9bf70effd913, sha256 975e26c1c8eef435209395a0a843a9f68573684c4d93aad5de5acf674f9f7f8f)
BibTeX
@misc{dc9bf70effd913,
title = {The integrated analysis of PRDX3 in lung cancer: biomarker potential and therapeutic target prospects — Europe PMC PMID:42092925},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/42092925},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_9bf70effd913; sha256 975e26c1c8eef435209395a0a843a9f68573684c4d93aad5de5acf674f9f7f8f},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42092925. Agents can read the archived copy with the MCP tool read_document.